6.03
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Diamedica Therapeutics Inc Borsa (DMAC) Ultime notizie
Full technical analysis of DiaMedica Therapeutics Inc. stockJuly 2025 Momentum & Accurate Trade Setup Notifications - Newser
Can machine learning forecast DiaMedica Therapeutics Inc. recoveryJuly 2025 Breakouts & AI Optimized Trade Strategies - Newser
Custom strategy builders for tracking DiaMedica Therapeutics Inc.Market Risk Summary & Community Consensus Picks - Newser
Identifying reversal signals in DiaMedica Therapeutics Inc.Profit Target & Step-by-Step Trade Execution Guides - Newser
Technical signs of recovery in DiaMedica Therapeutics Inc.Long Setup & Free Growth Oriented Trading Recommendations - Newser
Statistical indicators supporting DiaMedica Therapeutics Inc.’s strengthTrend Reversal & Safe Entry Momentum Tips - Newser
What indicators show strength in DiaMedica Therapeutics Inc.Analyst Downgrade & Risk Managed Investment Signals - Newser
What to expect from DiaMedica Therapeutics Inc. in the next 30 daysGap Up & Reliable Entry Point Trade Alerts - Newser
Is this a good reentry point in DiaMedica Therapeutics Inc.July 2025 Earnings & Reliable Entry Point Alerts - Newser
Technical analysis overview for DiaMedica Therapeutics Inc. stockJuly 2025 PostEarnings & Weekly Breakout Opportunity Watchlist - Newser
Will DiaMedica Therapeutics Inc. see short term momentumWeekly Volume Report & Free Community Consensus Stock Picks - Newser
What’s the MACD signal for DiaMedica Therapeutics Inc.Entry Point & Weekly Watchlist for Hot Stocks - classian.co.kr
DiaMedica Therapeutics Inc (DMAC) Stock: 52-Week Performance Insights and Trading Volume - investchronicle.com
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q2 2025 Earnings Call Transcript - Insider Monkey
DiaMedica advances DM199 programs with $60M cash runway and expanded clinical trials - MSN
DiaMedica Therapeutics Advances with Positive Trials and Funding - TipRanks
Intrinsic Value of DiaMedica Therapeutics Inc. Stock: Is It Undervalued or OvervaluedShare Buyback & Real-Time Buy Signal Notifications - Newser
DiaMedica Therapeutics reports Q2 EPS (18c), consensus (19c) - MSN
DiaMedica: Interim Results Brings Study Expansions For DM199 In Preeclampsia (NASDAQ:DMAC) - Seeking Alpha
Diamedica Therapeutics shares rise 14.94% intraday after Celcuity's positive Phase 3 trial results. - AInvest
DiaMedica Therapeutics Q2 2025 Earnings Call Transcript - MarketBeat
Diamedica Therapeutics shares rise 1.92% intraday after Q2 2025 earnings call. - AInvest
Earnings call transcript: DiaMedica Therapeutics Q2 2025 shows promising trials By Investing.com - Investing.com South Africa
Earnings call transcript: DiaMedica Therapeutics Q2 2025 shows promising trials - Investing.com India
Pattern recognition hints at DiaMedica Therapeutics Inc. upside2025 Trade Ideas & Fast Gain Stock Tips - Newser
DiaMedica Posts Narrower Loss in Q2 - AOL.com
DiaMedica Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights - BioSpace
DiaMedica Therapeutics Enters Sales Agreement with TD Securities - TipRanks
DiaMedica Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Can DiaMedica Therapeutics Inc. sustain its profitabilityReal-Time Trade Breakout Scanner - thegnnews.com
Screener Results Flag DiaMedica Therapeutics Inc. as OversoldROI Driven Equity Selection With Safety Emphasized - 선데이타임즈
What data driven models say about DiaMedica Therapeutics Inc.’s futureRapid Trade Forecast Based on Indicators - Newser
Momentum divergence signals in DiaMedica Therapeutics Inc. chartAutomated AI Forecast with Trading Alerts - Newser
Fair Value Estimate for DiaMedica Therapeutics: $5.11; Share Price Matches Fair Value; Analyst Price Target Exceeds Fair Value. - AInvest
Volume spikes in DiaMedica Therapeutics Inc. stock – what they meanShort-Term AI-Based Stock Price Forecast - Newser
What’s the recovery path for long term holders of DiaMedica Therapeutics Inc. - Newser
What makes DiaMedica Therapeutics Inc. stock price move sharplyFree AI Based High Gain Watchlist Scanner - Newser
Press Release: DiaMedica Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update August 13, 2025 - 富途牛牛
Can momentum traders help lift DiaMedica Therapeutics Inc.Free Low Risk Buy Zone Opportunity Watch - Newser
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):